ARMISTICE CAPITAL LLC 13D and 13G filings for Paratek Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2020-02-14 3:28 pm Sale | 2020-02-14 | 13G | Paratek Pharmaceuticals, Inc. PRTK | ARMISTICE CAPITAL LLC | 1,258,000 3.800% | -710,000 (-36.08%) | Filing |